Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors

Maria S. Legina(University of Vienna), Bernhard K. Keppler(University of Vienna)
JBIC Journal of Biological Inorganic Chemistry
March 19, 2020
10.1007/s00775-020-01775-2
Cited by 19

Related Papers

Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines
|Investigational New Drugs|2016|121
Triapine and a More Potent Dimethyl Derivative Induce Endoplasmic Reticulum Stress in Cancer Cells
|Molecular Pharmacology|2014|39
Influence of reducing agents on the cytotoxic activity of platinum(<scp>iv</scp>) complexes: induction of G2/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines
|Metallomics|2015|38
Anticancer Tungstenocenes with a Diverse Set of (O,O–), (O,S–) and (O,N–) Chelates—A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models
|Pharmaceutics|2023|2